The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preclinical study of adoptive immunotherapy with natural killer cells in metastatic colorectal cancer.
Silvia Brugnatelli
No relevant relationships to disclose
Ilaria Turin
No relevant relationships to disclose
Mariangela Manzoni
No relevant relationships to disclose
Marcello Maestri
No relevant relationships to disclose
Enrica Montini
No relevant relationships to disclose
Laura Caliogna
No relevant relationships to disclose
Marco Paulli
No relevant relationships to disclose
Paolo Dionigi
No relevant relationships to disclose
Andrea Pietrabissa
No relevant relationships to disclose
Sara Delfanti
No relevant relationships to disclose
Bianca Rovati
No relevant relationships to disclose
Sara Mariucci
No relevant relationships to disclose
Rita Maccario
No relevant relationships to disclose
Paolo Pedrazzoli
No relevant relationships to disclose
Daniela Montagna
No relevant relationships to disclose